Elevated WBC with Neutrophilia in Elderly Patient with Gastroenteritis
This laboratory pattern (WBC 11.4, neutrophils 9.38,82.3%) indicates a moderate bacterial infection that requires immediate evaluation for Clostridioides difficile infection (CDI), particularly given the patient's age and gastrointestinal symptoms.
Interpretation of Laboratory Values
The patient demonstrates:
- Mild leukocytosis (WBC 11.4 × 10³/µL, normal upper limit ~11)
- Absolute neutrophilia (9.38 × 10³/µL)
- Marked neutrophil predominance (82.3%, normal ~40-70%)
This pattern represents a left shift with neutrophilic leukocytosis, which strongly suggests active bacterial infection rather than viral gastroenteritis 1. The sudden and significant neutrophil predominance is characteristic of bacterial processes, as other stimuli rarely produce such marked changes 1.
Clinical Significance in Gastroenteritis Context
Primary Concern: Clostridioides difficile Infection
The WBC count of 11.4 × 10³/µL places this patient in the "non-severe" CDI category according to IDSA/SHEA guidelines 2. The guideline defines:
- Non-severe CDI: WBC ≤15,000 cells/mL AND creatinine <1.5 mg/dL
- Severe CDI: WBC ≥15,000 cells/mL OR creatinine >1.5 mg/dL
While below the severe threshold, this degree of leukocytosis with neutrophilia in a 76-year-old with gastroenteritis warrants:
- Immediate CDI testing (stool for C. difficile toxin/PCR)
- Assessment of recent antibiotic exposure (within past 3 months)
- Evaluation for dehydration (check creatinine to complete severity assessment)
Alternative Bacterial Etiologies
The neutrophilic pattern also suggests consideration of:
- Bacterial gastroenteritis (Salmonella, Campylobacter, Shigella)
- Intra-abdominal infection (diverticulitis, cholecystitis, appendicitis)
- Bowel ischemia (particularly in elderly patients)
Prognostic Implications
In upper GI bleeding contexts (which may coexist with gastroenteritis), leukocytosis at this level correlates with:
- More severe bleeding episodes
- Increased transfusion requirements
- Longer hospitalizations
- Higher surgical intervention rates 3
The combination of age 76 years plus leukocytosis indicates increased risk for complicated course 4.
Immediate Management Algorithm
Obtain stool studies immediately:
- C. difficile testing (toxin + PCR if available)
- Bacterial culture if diarrhea present
- Fecal leukocytes/lactoferrin
Assess severity markers:
- Serum creatinine (to determine CDI severity classification)
- Vital signs (hypotension, tachycardia suggest severe infection)
- Lactate if sepsis suspected
Consider empiric treatment if:
- Substantial delay in CDI test results expected
- Clinical deterioration
- High suspicion based on risk factors (recent antibiotics, hospitalization)
If CDI confirmed with non-severe disease:
- Vancomycin 125 mg PO four times daily × 10 days OR
- Fidaxomicin 200 mg PO twice daily × 10 days
- These are preferred over metronidazole (strong recommendation, high quality evidence) 2
Critical Pitfalls to Avoid
- Do not dismiss as "mild" leukocytosis: In elderly patients with GI symptoms, even moderate elevation signals significant bacterial process 5
- Do not use metronidazole as first-line: Guidelines strongly favor vancomycin/fidaxomicin for initial CDI episodes 2
- Monitor for progression to severe disease: If WBC rises to ≥15,000 or creatinine increases, severity classification changes
- Exclude malignancy if persistent: While acute infection is most likely, unexplained persistent leukocytosis requires hematologic evaluation 6
The neutrophil left shift reflects real-time neutrophil consumption during active bacterial infection 1, making serial WBC monitoring valuable for tracking treatment response and detecting clinical deterioration.